GFA First Aid

Manufacturer
Genuine First Aid, LLC
Effective date
2011-05-04
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:27:55

Label at a glance#

ProductGFA First Aid 24 Unit Metal Case
Active ingredientBENZALKONIUM CHLORIDE, LIDOCAINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, POVIDONE-IODINE
Label structure52 sections

Indications and uses

First aid to help prevent infection and for the temporary relief of pain and itching associated with: Minor Cuts Scrapes Burns

Dosage and administration

Tear open packet, unfold towelette and use to cleanse desired skin area.  Discard towelette appropriately after single use.

Storage and handling

Other Information: Store at room temperature (do not freeze). Taper evident sealed packets. Do not use packet if opened or torn.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient:                        

Benzalkonium Chloride 0.40%

Purpose

OTC - PURPOSE SECTION


Antiseptic

Use

INDICATIONS & USAGE SECTION

For Professional and Hospital use.  Helps prevent infection.  Antiseptic cleansing of face, hands and body without soap and water.

Warnings

WARNINGS SECTION

Warning:   For external use only.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children:  If swallowed, get medical help or contact a Poison Control Center right away.

OTC - STOP USE SECTION

Stop use if unusual redness, swelling or other symptoms occur. Consult a physician immediately.

OTC - DO NOT USE SECTION

Do not use in the eyes or over large areas of the body.

Directions

DOSAGE & ADMINISTRATION SECTION

Tear open packet, unfold towelette and use to cleanse desired skin area.  Discard towelette appropriately after single use.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredient:   Purified water

SPL UNCLASSIFIED SECTION

LOT/EXP:                           Made in CHINA

20130301

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Antiseptic Towelette

Genuine First Aid LLC, Clearwater FL 33755

www.GenuineFirstAid.com

1/pouch

GENUINE FIRST AID

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS:

Benzalkonium Chloride 0.13%
Lidocaine HCL 0.5%


Purpose

OTC - PURPOSE SECTION

Purpose: First aid antiseptic, external analgesic


Uses

INDICATIONS & USAGE SECTION

First aid to help prevent infection and for the temporary relief of pain and itching associated with:

Minor Cuts

Scrapes

Burns

Warnings

WARNINGS SECTION


For external  use only

OTC - DO NOT USE SECTION

Do not use: In eyes, in large quantities, over raw blistered areas, or on deep puncture wounds, animal bites or serious burns, for more than one week

Do not use:
in the eyes or apply over large areas of the body.
longer than 1 week unless directed by a doctor.
in large quantities, particularly over raw surfaces or blistered areas.

Ask a doctor before use if you have deep puncture wounds, animal bites or serious burns.

When using this product, avoid contact with the eyes.

OTC - STOP USE SECTION


Stop use and ask a doctor if
condition worsens
symptoms persist for more than 7 days
condition clears up and occurs again within a few days

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of Children.

If ingested, contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION



Adults and children 2 years of age and older

clean affected area.

apply a small amount of this product on the area 1 to 3 times daily.

may be covered with a sterile bandage

children under 2 years of age: consult a doctor

STORAGE AND HANDLING SECTION

Other Information:

Store at room temperature (do not freeze).

Taper evident sealed packets.

Do not use packet if opened or torn.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Aloe vera, cetyl alcohol, diazolidinyl urea, edetate disodium, glycerin, glyceryl monostearate, methylparaben, mineral oil, polyethylene glycol, propylene glycol, propylparaben, purified water, stearic acid, irolamine

DESCRIPTION SECTION

LOT/EXP:                                    Made in CHINA

20130301


GFA Production Xiamen Co., Ltd
No. 20 Huli Industrial Park, Meixi Road, Tong'an, Xiamen, Fujian, China 361100
Tel: 86-592-7269515 Fax: 86-592-7269528 Http: //www.gfaproduction.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Genuine First Aid Burn Cream

Antiseptic Pain Relief With Aloe

Net Wt 0.9g (1/32 oz)

Manufactured in CHINA for

Genuine First Aid.

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: .........Bacitracin Zinc 400 units

Neomycin Sulfate 5mg ( equivalent to 3.5 mg Neomycin base)

Polymyxin B Sulfate 5000 units

Purpose

OTC - PURPOSE SECTION

Triple Antibiotic

INDICATIONS & USAGE SECTION

Uses:  To help prevent infection in:
minor cuts;  scrapes;  burns

Warnings

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use:  in eyes;  over large areas of the body;

If allergic to any of the ingredients;  for more than one week unless directed by a physician.

OTC - STOP USE SECTION

Stop use and consult a doctor:

if the condition persists or gets worse;  a rash or other allergic reaction develops

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If ingested, contact a Poison

Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions: clean affected area;  apply small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily; may be covered with a sterile bandage

STORAGE AND HANDLING SECTION

Other information:

Store at room temperature.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

water

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Genuine Triple Antibiotic

First Aid Ointment

To Help Prevent Infection

Each Gram Contains:

Bacitracin Zinc 400 units

Neomycin Sulfate 5 mg

(equivalent to 3.5 mg

Neomycin base)

 Polymyxin B Sulfate 5000 units

Net Wt. 0.5g ; (1/64 oz)

Manufactured in CHINA for

GENUINE FIRST AID.


Triple Antibiotic Ointment 10pcs

Net wt. 0.9g (1/32oz)


100
Triple Antibiotic

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

One Prep pad saturated with a 10% Povidone-Iodine solution equivalent to 1% available iodine

Purpose

OTC - PURPOSE SECTION

antiseptic, germicidal

Uses

INDICATIONS & USAGE SECTION

Provides, antiseptic germicidal skin preperation for minor invasive procedures

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

For external use only.

Caution

WARNINGS SECTION

In case of deep or puncture wounds or serious burns, and if pain, irritation, redness, swelling or infection occurs, discontinue use and contact a physician.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purified water.

Directions

DOSAGE & ADMINISTRATION SECTION

Clean intended area thoroughly with pad. Discard after single use.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Antiseptic
Povidone-Iodine
Prep Pads
 medium
Saturated with a 10% Povidone-Iodine
Solution equavalent to 1% available iodine

GFA Production Xiamen Co., Ltd.
www.gfaproduction.com

GFA Production Xiamen Co., Ltd.
No. 20 Huli Industrial Park, Meixi Road,
Tong'an, Xiamen, Fujian, China 361100

Wellkang Ltd t/a Wellkang Tech Consulting
Suite B, 29 Harley Street
LONDON W1G 9QR, England, United Kingdom

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Povidone-Iodine Prep PadsPovidone-Iodine Prep Pads

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Povidone-Iodine Prep PadsPovidone-Iodine Prep Pads

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Genuine Triple AntibioticGenuine Triple Antibiotic

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Genuine Triple AntibioticGenuine Triple Antibiotic

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Burn CreamBurn Cream

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Burn CreamBurn Cream

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Antiseptic ToweletteAntiseptic Towelette

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Antiseptic ToweletteAntiseptic Towelette

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GFA First Aid KitGFA First Aid Kit

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GFA First Aid KitGFA First Aid Kit

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
204602bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical OintmentPSN2
1012100benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical CreamPSN2
1038561benzalkonium Cl 0.4 % Medicated PadPSN2
797730povidone-iodine 10 % Medicated PadPSN2
204602bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical OintmentSCD2
1012100benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical CreamSCD2
1038561benzalkonium chloride 4 MG/ML Medicated PadSCD2
797730povidone-iodine 100 MG/ML Medicated PadSCD2
204602bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical OintmentSY2
1012100benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical CreamSY2
1038561benzalkonium chloride 0.4 % Medicated ToweletteSY2
1038561benzalkonium chloride 0.4 % Topical SwabSY2
797730povidone-iodine 10 % (titratable iodine 1 % ) Medicated PadSY2
797730povidone-iodine 10 % Medicated PadSY2
797730povidone-iodine 10 % Medicated SwabstickSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BACITRACIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
NEOMYCIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
POLYMYXIN B Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
99e684e6-f435-feb8-d2bb-3a546f1cb768Product name220161117
25340b3b-3e4c-4ff8-abf6-3e62ec46bd0cProduct name120160603
2d352c73-a357-4193-a4de-dfdf9a2ac8e4Product name120150819
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421
b045ad64-0f28-9a02-2f9b-b34d94fb2278Product name120140508
b6082387-f592-1148-0844-bd068fd213fbProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
52124-1166-42019-10-29C16284748780-1960f7f55-cea2-8e05-e053-dbdaa90a074aGFA First Aid Kit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52124-0001-2GFA First Aid24 Unit Metal Case10 in 1 BOXSWAB0.4 mL in 100mL2
52124-0001-2GFA First Aid24 Unit Metal Case0.8 mL in 1 PACKETSWAB8.0 mL0.4 mL in 100mL2
52124-0003-2GFA First Aid24 Unit Metal Case0.5 g in 1 TUBEOINTMENT5.0 g5 mg in 1g2
52124-0003-2GFA First Aid24 Unit Metal Case10 in 1 BOXOINTMENT5000 [iU] in 1g2
52124-0004-2GFA First Aid24 Unit Metal Case6 in 1 BOXCREAM0.5 g in 100g2
52124-0004-2GFA First Aid24 Unit Metal Case0.9 g in 1 PACKETCREAM5.4 g0.13 g in 100g2
52124-1166-4GFA First Aid24 Unit Metal Case1 in 1 KITKIT12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52124-0001GFA FIRST AID (BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE, LIDOCAINE, POVIDONE-IODINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B) KIT [GENUINE FIRST AID, LLC]2Legacy NDC20110506_eb877f27-8277-4ad4-816e-48de54f3a562.zip
52124-0003GFA FIRST AID (BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE, LIDOCAINE, POVIDONE-IODINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B) KIT [GENUINE FIRST AID, LLC]2Legacy NDC20110506_eb877f27-8277-4ad4-816e-48de54f3a562.zip
52124-0004GFA FIRST AID (BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE, LIDOCAINE, POVIDONE-IODINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B) KIT [GENUINE FIRST AID, LLC]2Legacy NDC20110506_eb877f27-8277-4ad4-816e-48de54f3a562.zip
52124-1166GFA FIRST AID (BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE, LIDOCAINE, POVIDONE-IODINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B) KIT [GENUINE FIRST AID, LLC]2Legacy NDC, 7 package rows20110506_eb877f27-8277-4ad4-816e-48de54f3a562.zip
52124-2901GFA FIRST AID (BENZALKONIUM CHLORIDE, BENZALKONIUM CHLORIDE, LIDOCAINE, POVIDONE-IODINE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B) KIT [GENUINE FIRST AID, LLC]2Legacy NDC20110506_eb877f27-8277-4ad4-816e-48de54f3a562.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BACITRACIN ZINCACTIVE INGREDIENT89Y4M234ES2
BENZALKONIUM CHLORIDEACTIVE INGREDIENTF5UM2KM3W72
LIDOCAINEACTIVE INGREDIENT98PI2009872
NEOMYCIN SULFATEACTIVE INGREDIENT057Y6266932
POLYMYXIN B SULFATEACTIVE INGREDIENT19371312D42
POVIDONE-IODINEACTIVE INGREDIENT85H0HZU99M2
BACITRACINACTIVE MOIETY58H6RWO52I2
BENZALKONIUMACTIVE MOIETY7N6JUD5X6Y2
IODINEACTIVE MOIETY9679TC07X42
LIDOCAINEACTIVE MOIETY98PI2009872
NEOMYCINACTIVE MOIETYI16QD7X2972
POLYMYXIN BACTIVE MOIETYJ2VZ07J96K2
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN2
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW42
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K2
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE42
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T2
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP2
POLYETHYLENE GLYCOLINACTIVE INGREDIENT3WJQ0SDW1A2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 32 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 480 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRA-ARTICULAR0.24 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRAVENOUS10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SUSPENSION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / VAGINAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION, AUGMENTED / TOPICAL2070 mgExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / ORAL388 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAVENOUS95 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAMUSCULAR95 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSPRAY / NASAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, CHEWABLE / ORAL1 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGUM, CHEWING / BUCCAL230 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / ORAL64 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TDROPS / ORAL1 mg/1mlExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXJELLY / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, COATED / ORAL0.25 mgExact identifier — unii candidate
20 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSHAMPOO, SUSPENSION / TOPICAL0.15 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
DIAZOLIDINYL UREADIAZOLIDINYL UREAH5RIZ3MPW4CREAM / TOPICAL29 mgExact identifier — unii candidate
3 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPLOTION / TOPICAL1428 mgExact identifier — unii candidate
30 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
77 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, FILM COATED / ORAL176 mgExact identifier — unii candidate
26 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / ORAL29008 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHEMULSION / TOPICAL0.06 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, EFFERVESCENT / ORAL32 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / RECTAL0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / ORAL100 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / VAGINAL22 mgExact identifier — unii candidate
79 equally ranked IID candidates
DIAZOLIDINYL UREADIAZOLIDINYL UREAH5RIZ3MPW4OINTMENT / TOPICAL0.1 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KLOTION / TOPICAL22 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / VAGINAL8 mgExact identifier — unii candidate
79 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNOINTMENT / TOPICAL7 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APAEROSOL, FOAM / TOPICAL8 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / NASAL14 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APEMULSION / TOPICALNAExact identifier — unii candidate
26 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / PARENTERAL18 mgExact identifier — unii candidate
79 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPFILM / TRANSDERMAL11.42 mgExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION, CONCENTRATE / ORAL0.2 mg/1mlExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION / RESPIRATORY (INHALATION)0.01 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCAPSULE / ORAL1 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS19 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / IONTOPHORESIS0.1 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, CHEWABLE / ORAL12 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSYSTEM / IONTOPHORESIS0.1 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET / ORAL33.34 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET / ORAL64 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
da4c53fb-cb3b-4efa-a402-03b644217945eb877f27-8277-4ad4-816e-48de54f3a5622011-05-04WarningsExact identifier
spl id: da4c53fb-cb3b-4efa-a402-03b644217945
spl set id: eb877f27-8277-4ad4-816e-48de54f3a562

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.